SNT 2.94% 3.3¢ syntara limited

Ann: Pharmaxis Announces Positive Combined Phase , page-10

  1. 1,571 Posts.
    re: Ann: Pharmaxis Announces Positive Combine... Interesting the comparison to rhdnase the main product on the market and the upside benefits! Surprised there has not been more chat on here about it.

    Does anyone know whether there are any comparisons though to other phase 3 drugs that have either been approved recently or about to be approved?
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.